ALFA Filings
Every announcement, straight from the exchange
Every Divi's Laboratories other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
8 announcements with these filters
Divis Laboratories Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31.
Immediate relatives of the company purchased 462 shares for a total consideration of Rs. 0.43 Crore in the open market.
Divis Laboratories Ltd reported a share pledge by Designated Person Nimmagadda Venkata Anirudh involving securities valued at ₹3.33 Crore. Additionally, Joshita Divi acquired shares worth ₹0.96 Crore via market purchase.
An immediate relative of a Divis Laboratories promoter bought equity shares worth ₹0.58 Crore through a market purchase.
Designated Person PRASAD Y.T.S. disclosed the release of two share pledges involving 2,734 equity shares. The combined transaction value of the released pledges is Rs. 2.56 Crore.
Designated person PRASAD Y.T.S. sold 6,234 equity shares of Divis Laboratories Ltd for ₹5.84 Crore via market sale.
K. Sridevi, an immediate relative, sold 200 equity shares of Divi's Laboratories Ltd in a market transaction valued at ₹18.56 Lakh.
Divis Laboratories Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. This routine regulatory disclosure details the distribution of equity shares.